Role of hospital-based cancer registry in planning the cancer control program in semiurban setting in Alandi, Pune, Maharashtra, India.

S Sanjay P. Deshmukh (Indrayani Hospital and Cancer Institute, Pune, India) M Manjiri Shriniwas Joshi (Indrayani Hospital and Cancer Institute, Pune, India) R Rajeev Joshi (UGC-DAE Consortium for Scientific Research, University Campus 3 , Khandwa Road, Indore 452001,) N Nitin Gosavi (Indrayani Hospital and Cancer Institute, Pune, India) S Shrikant Ankolikar (Indrayani Hospital and Cancer Institute, Pune, India) S Shailesh Naik (Indrayani Hospital and Cancer Institute, Pune, India) B Bhooshan Zade (Indrayani Hospital and Cancer Institute, Pune, India) J Jayant Shankar Gawande (Indrayani Hospital and Cancer Institute, Pune, India) A Asma Pathan (MOC Cancer Care & Research Centre, Pune, India) R Ravi Wategaonkar (MOC Cancer Care & Research Centre, Pune, India) S Sachin Wagh (Indrayani Hospital and Cancer Institute, Pune, India) S Sonali Sanjay Deshmukh (Indrayani Hospital and Cancer Institute, Pune, India) P Parul Gupta D Darshana Kawale (Indrayani Hospital and Cancer Institute, Pune, maharashtra, India) N Nandini` Chouhan (Indrayani Hospital and Cancer Institute, Pune, India) D Dinesh Chaudhari (Indrayani Hospital and Cancer Institute, Pune, India) A Anjali Uniyal (Indrayani Hospital and Cancer Institute, Pune, India) R Rahul Pavshere (Indrayani Hospital and Cancer Institute, Pune, India) P Pranoti Chiwarkar (Indrayani Hospital and Cancer Institute, Pune, India) A Atul Budukh (Tata Memorial Centre, Mumbai, India)

Abstract

e22566 Background: Indrayani Hospital and Cancer Institute (IHCI) in Maharashtra, India, has provided comprehensive cancer care to underserved populations since 2008. In 2020, IHCI established a Hospital-Based Cancer Registry (HBCR) to systematically document cancer burden and treatment patterns. The objective of the study is to showcase how HBCR data is leveraged to plan cancer control activities, specifically developing an Early Detection Program (EDP) for oral, breast, and cervical cancers, which are the most prevalent cancers in India. Methods: The HBCR analyzed registered cases from 2019 to 2023. Clinical and demographic data were coded using ICD-O3 and analyzed using CanReg5 and STATA. Trends in incidence, disease stage, and treatment outcomes were studied to identify care delivery gaps and guide early detection strategies. Based on HBCR finding the technical committee felt the need for raising cancer awareness on the commonly occurring cancers. Results: From 2019 to 2023, 7,810 cancer cases were registered, with 3,788 males and 4,022 females. Oral cancer was the leading cancer among males (1,667; 44%), while breast cancer was predominant among females (1,196; 30%). Tobacco-related cancers accounted for 66% (2,500) of male cases. Approximately 93% (3,730) of oral, breast, and cervical cancer cases presented at loco-regional stages, underscoring the necessity of early detection. Treatment completion rates were 70% (5,430), and 87% (6,799) of patients benefited from financial support through the Mahatma Jyotiba Phule Jan Arogya Yojana (MJPJAY). Conclusions: HBCR data offered vital epidemiological insights, shaping a comprehensive EDP modeled on the TMC Sangrur 1 initiative. The program incorporates community-based selective screening for oral, breast, and cervical cancers, capacity building for primary care providers, and alignment with public health infrastructure. This study underscores the significance of registry-driven evidence in cancer prevention and control strategies in resource-limited settings.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (20)

S

Sanjay P. Deshmukh

Indrayani Hospital and Cancer Institute, Pune, India

M

Manjiri Shriniwas Joshi

Indrayani Hospital and Cancer Institute, Pune, India

R

Rajeev Joshi

UGC-DAE Consortium for Scientific Research, University Campus 3 , Khandwa Road, Indore 452001,

N

Nitin Gosavi

Indrayani Hospital and Cancer Institute, Pune, India

S

Shrikant Ankolikar

Indrayani Hospital and Cancer Institute, Pune, India

S

Shailesh Naik

Indrayani Hospital and Cancer Institute, Pune, India

B

Bhooshan Zade

Indrayani Hospital and Cancer Institute, Pune, India

J

Jayant Shankar Gawande

Indrayani Hospital and Cancer Institute, Pune, India

A

Asma Pathan

MOC Cancer Care & Research Centre, Pune, India

R

Ravi Wategaonkar

MOC Cancer Care & Research Centre, Pune, India

S

Sachin Wagh

Indrayani Hospital and Cancer Institute, Pune, India

S

Sonali Sanjay Deshmukh

Indrayani Hospital and Cancer Institute, Pune, India

P

Parul Gupta

D

Darshana Kawale

Indrayani Hospital and Cancer Institute, Pune, maharashtra, India

N

Nandini` Chouhan

Indrayani Hospital and Cancer Institute, Pune, India

D

Dinesh Chaudhari

Indrayani Hospital and Cancer Institute, Pune, India

A

Anjali Uniyal

Indrayani Hospital and Cancer Institute, Pune, India

R

Rahul Pavshere

Indrayani Hospital and Cancer Institute, Pune, India

P

Pranoti Chiwarkar

Indrayani Hospital and Cancer Institute, Pune, India

A

Atul Budukh

Tata Memorial Centre, Mumbai, India